Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Hospital


Location: Mainz, Germany (DE) DE

ISNI: -

ROR: https://ror.org/00q1fsf04

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment (2026) Petzke TM, Köteles F, Kessler H, Doering S, Kehyayan A, Pape M, Hofmann T, et al. Journal article Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial (2026) Smits PC, Włodarczak A, Chevalier B, West NE, Gori T, Abdel-Wahab M, Barbato E, et al. Journal article Erratum to: 40 Jahre Deutsche Gesellschaft für Geriatrie (DGG) – gefragt, gereift, gestärkt: Geschichte der DGG unter wissenschaftlichen und fachpolitischen Aspekten (Zeitschrift für Gerontologie und Geriatrie, (2025), 58, 5, (405-424), 10.1007/s00391-025-02460-2) (2026) Hofmann W, Grund S, Wirth R, Bauer JM, Heppner HJ, Thiem U, Becher K, et al. Journal article, Erratum Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Multidisciplinary guidelines on renal replacement therapy in intensive care medicine (2026) Meersch-Dini M, Abu-Tair M, Bayer M, Brinkmann A, Bellmann R, Brunkhorst F, Custodis F, et al. Journal article, Review article Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). (2026) Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, et al. Journal article Treatment differences in IDH–wildtype glioma – the impact of surgery and adjuvant therapy (2026) Keric N, Krenzlin H, Lange F, Dauth A, Freyschlag CF, Schnellg O, Misch M, et al. Journal article Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort study (2026) Trommer M, Rühle A, Lamrani A, Frei C, Kaufmann J, Mäurer M, Wurschi G, et al. Journal article Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland (2026) Simon L, Vucinic V, Rejeski K, Schubert ML, Aydilek E, Wagner-Drouet EM, Penack O, et al. Journal article